Craig Clifford, DPM
Foot & Ankle Surgery · Federal Way, WANPI 1104142686
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.8%), education and speaking fees — rather than concentrated in one kind of arrangement. Paragon 28, Inc. accounts for 61.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $25,621 and has fallen 99.8% since, to $63 in 2025. Among foot & ankle surgery clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 67 payments — averaging $649.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$27K
- Summit Surgical Corp.$9K
- Arthrex$6K
- Stryker$223
- Axogen$149
- Arteriocyte Medical Systems, Inc.$145
- plus $494 from 9 others
What the payments were for
- Consulting fees$22,09451%
- Speaking & faculty fees$5,00011%
- Travel & lodging$4,1209%
- Food & beverage$1,8834%
- Education$10,40424%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 18 | $26,638 |
| Summit Surgical Corp. | 9 | $9,355 |
| Arthrex | 15 | $6,495 |
| Stryker(2 entities) | 6 | $223 |
| Axogen | 2 | $149 |
| Arteriocyte Medical Systems, Inc. | 1 | $145 |
| Smith+Nephew | 2 | $143 |
| Orthofix Medical, Inc. | 4 | $85 |
| Amgen | 1 | $83 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $53 |
| Exact Sciences | 2 | $41 |
| Integra Lifesciences Corporation | 1 | $32 |
| Bioventus LLC | 1 | $29 |
| Medtronic | 1 | $16 |
| Zimvie Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$832
- APEX TAR$554
- Grafix$125
- GRAFIX PL$125
- Stravix$125
- AxoGuard Nerve Protector$123
- AxoGuard Nerve Connector$123
- MICA$107
How this compares
$43,500 in reported general payments places this provider in the 95th percentile of 203 foot & ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 50 | $1,165 |
| Gabapentin | 22 | $221 |
| Meloxicam | 25 | $104 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $63 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Federal Way
- Emily WaglerFederal Way$16K
- Alissa MayerFederal Way$7K
- Jeffrey ChristensenEverett$828K
- David DalstromSeattle$491K
- Richard LamourOlympia$87K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Shawn KhademiRenton$43K
- Gregory GrabowskiBellevue$34K
- Jacob McLeodLongview$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.